Panagora Asset Management Inc Catalyst Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

  • $20.5 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$4.85 - $6.04 $8,633 - $10,751
-1,780 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$4.29 - $6.05 $31,587 - $44,546
-7,363 Reduced 80.53%
1,780 $10,000
Q1 2021

May 12, 2021
SELL
$3.45 - $4.69 $25,067 - $34,077
-7,266 Reduced 44.28%
9,143 $42,000
Q4 2020

Feb 10, 2021
SELL
$2.97 - $3.83 $3,442 - $4,438
-1,159 Reduced 6.6%
16,409 $55,000
Q1 2020

May 14, 2020
SELL
$2.61 - $5.21 $624,236 - $1.25 Million
-239,171 Reduced 93.16%
17,568 $67,000
Q4 2019

Feb 12, 2020
SELL
$3.67 - $5.7 $158,962 - $246,889
-43,314 Reduced 14.44%
256,739 $963,000
Q3 2019

Nov 12, 2019
BUY
$3.89 - $7.43 $10,950 - $20,915
2,815 Added 0.95%
300,053 $1.59 Million
Q1 2019

May 15, 2019
SELL
$2.11 - $5.33 $660,031 - $1.67 Million
-312,811 Reduced 51.28%
297,238 $1.52 Million
Q4 2018

Feb 14, 2019
SELL
$1.92 - $3.62 $2,689 - $5,071
-1,401 Reduced 0.23%
610,049 $1.17 Million
Q3 2018

Nov 13, 2018
BUY
$2.81 - $3.78 $938,037 - $1.26 Million
333,821 Added 120.24%
611,450 $2.31 Million
Q2 2018

Aug 14, 2018
BUY
$2.26 - $3.84 $503,720 - $855,878
222,885 Added 407.14%
277,629 $866,000
Q1 2018

May 15, 2018
BUY
$2.39 - $4.01 $130,838 - $219,523
54,744 New
54,744 $131,000

Others Institutions Holding CPRX

# of Institutions
332
Shares Held
94.7M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.46B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email